To determine whether FOXP4 is a downstream target molecule of the androgen/AR pathway in endometrial cancer, we performed a Chip-sequence assay and found that androgen/AR or its transcription complex bound to intron 1 of the hFOXP4 coding region of AR_HEC50B cells (Supplementary Fig. 1e). Here, FOXP4 is linked to endometrial cancer.